Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 700 | 1,738 | 2,463 | 2,214 |
| Marketable Securities | 41 | 32 | 54 | 19 |
| Receivables | 293 | 212 | 175 | 152 |
| Other current assets | 0 | 0 | 0 | 451 |
| TOTAL | $1,634 | $1,982 | $2,692 | $2,836 |
| Non-Current Assets | ||||
| PPE Net | 759 | 158 | 51 | N/A |
| Other Non-Current Assets | 48 | 30 | 51 | 0 |
| TOTAL | $807 | $188 | $102 | $N/A |
| Total Assets | $2,441 | $2,170 | $2,794 | $2,836 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | N/A | 1,043 |
| Accounts payable and accrued liabilities | 232 | 317 | 298 | 259 |
| Accrued Expenses | 166 | 299 | 305 | 87 |
| Other current liabilities | N/A | 1,292 | N/A | 242 |
| TOTAL | $398 | $1,908 | $603 | $1,631 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 282 | 73 | 95 | 28 |
| TOTAL | $282 | $73 | $95 | $28 |
| Total Liabilities | $680 | $1,981 | $698 | $1,659 |
| Shareholders' Equity | ||||
| Retained earnings | -19,100 | -14,057 | -10,418 | -2,249 |
| Other shareholders' equity | 1,395 | 947 | 1,264 | 169 |
| TOTAL | $1,761 | $189 | $2,096 | $1,177 |
| Total Liabilities And Equity | $2,441 | $2,170 | $2,794 | $2,836 |